Lyra Therapeutics (LYRA) Net Margin (QoQ) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Lyra Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.54 Mn |
| Sep 30, 2025 | -1.99 Mn |
| Jun 30, 2025 | 60,656.00 |
| Mar 31, 2025 | 58,262.00 |
| Dec 31, 2024 | 83,561.00 |
| Sep 30, 2024 | 195,994.00 |
| Jun 30, 2024 | -382,836.00 |
| Mar 31, 2024 | 616,052.00 |
| Dec 31, 2023 | -750,380.00 |
| Sep 30, 2023 | 53,302.00 |
| Jun 30, 2023 | 55,459.00 |
| Mar 31, 2023 | 12.53 Mn |
| Dec 31, 2022 | -12.52 Mn |
| Sep 30, 2022 | -137,671.00 |
| Jun 30, 2022 | -19,130.00 |
| Mar 31, 2022 | 247,964.00 |
| Dec 31, 2021 | 7.39 Mn |